Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025CureusOpen Access

Reviving the Mitochondria: A Hopeful Horizon in Refractory Heart Failure

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZeeshan AhmedFRFaisal RehmanSBSyed Faqeer Hussain Bokhari

Discussion

Loading...

Member takes

Overview

This editorial reports advances in mitochondrial therapies for refractory heart failure, suggesting a paradigm shift in treatment.

Key Points

  • Mitochondrial dysfunction is central to the progression of refractory heart failure, leading to cell death and energy deficits.
  • Recent research shows that restoring mitochondrial function may significantly improve outcomes in patients with heart failure.
  • Exploration of new therapeutic strategies focuses on targeting mitochondrial health to mitigate oxidative stress and bioenergetic failure.
  • Challenges remain in translating these promising mitochondrial-targeted innovations into regular clinical practice.

Cite This Study

Ahmed et al. (2025) studied this question.

synapsesocial.com/papers/68c23caeb210217d6478ae7bhttps://doi.org/10.7759/cureus.91710
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pathophysiology of HFpEF: Insights from a Metabolic–Mitochondrial Perspective2025 · 12 citations
  2. 2The crosstalk between mitochondrial dysfunction and fatty acid metabolism in heart failure: mechanisms and therapeutic strategies2025
  3. 3Unraveling mitochondrial crosstalk: a new frontier in heart failure pathogenesis2025
  4. 4Oxidative Stress, Mitochondrial Quality Control, Autophagy, and Sirtuins in Heart Failure2025
  5. 5Oxidative Stress, Mitochondrial Quality Control, Autophagy, and Sirtuins in Heart Failure2025